VectorBuilder is hosting its next GDSS to catch up on Sam Booker's research.

As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, we have received glowing customer testimonials and numerous citations in high-impact publications. Operating as a multinational company with branches in North America, Europe, China, Japan, South Korea, and Australia, VectorBuilder has served over 50,000 customers from several thousand organizations worldwide, including universities, research institutions, biotech/pharma companies, and governmental agencies. So we ask you one question: Will you join us in the gene delivery revolution？